Antibody could be used to target tumor-causing protein, study shows
Wednesday, March 12, 2014 - 13:02
in Health & Medicine
Patients with advanced melanoma and kidney cancer who were treated with a certain antibody that targets a tumor-enhancing protein was safe, which could lead to more treatment options for patients, researchers have found in a phase-1 study. This study sheds light on a therapy that could be used alone or in combination to help patients with a number of cancers.